Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial.
Bahlis NJ, Corso A, Mugge LO, Shen ZX, Desjardins P, Stoppa AM, Decaux O, de Revel T, Granell M, Marit G, Nahi H, Demuynck H, Huang SY, Basu S, Guthrie TH, Ervin-Haynes A, Marek J, Chen G, Facon T.
Bahlis NJ, et al. Among authors: shen zx.
Leukemia. 2017 Nov;31(11):2435-2442. doi: 10.1038/leu.2017.111. Epub 2017 Apr 4.
Leukemia. 2017.
PMID: 28373701
Free PMC article.
Clinical Trial.